Recommendations to inform National Coverage Determination development for skin substitutes in hard-to-heal wounds
DOI:
https://doi.org/10.63676/g7eqg121Keywords:
Standard of care, Wound healing, PolicyAbstract
Rapid growth in Medicare use of skin substitutes (CAMPs) has improved wound outcomes but raised concerns about fraud, waste, and rising costs. Recent reimbursement reforms appear to have caused disruptions in patient access and care delivery. An expert consensus panel recommends a wound‑agnostic national coverage approach focused on clinical need, 30‑day reassessment, and clear discontinuation criteria, while deferring detailed standards of care to local policies.
References
Office of Inspector General, U.S. Department of Health & Human Services. Medicare Part B Payment Trends for Skin Substitutes Raise Major Concerns About Fraud, Waste, and Abuse. Report No. OEI‑BL‑24‑00420. Washington, DC: HHS; September 3, 2025. https://oig.hhs.gov/reports/all/2025/medicare-part-b-payment-trends-for-skin-substitutes-raise-major-concerns-about-fraud-waste-and-abuse/ (accessed 13 May 2026)
Centers for Medicare & Medicaid Services. Medicare Program: Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment Systems; payment policy for skin substitutes (CMS–1834–FC). Federal Register. 2025 Nov 25;90(225). https://www.federalregister.gov/documents/2025/11/25/2025-20907/medicare-program-hospital-outpatient-prospective-payment-system-and-ambulatory-surgical-center-payment (accessed 13 May 2026)
Wound and Hyperbaric Association. Early Reported Effects of the 2026 CMS Physician Fee Schedule on Access to Cellular, Acellular, and Matrix-Like Products in Wound Care: A National Clinician Survey. 2026. In press.
Centers for Medicare & Medicaid Services. Final local coverage determinations (LCDs) for certain skin substitutes withdrawn. Baltimore (MD): CMS; 2025 Dec 24 [cited 2026 Apr 27]. https://www.cms.gov/newsroom/fact-sheets/upcoming-update-final-local-coverage-determinations-lcds-certain-skin-substitutes (accessed 13 May 2026)
Centers for Medicare & Medicaid Services. HCPCS Level II code set and descriptor file [Internet]. Baltimore (MD): CMS; 2024 [cited 2026 Apr 27]. https://www.cms.gov/medicare/medicare-fee-for-service-payment/hcpcsreleasecodeset (accessed 13 May 2026)
Wu S, Carter M, Cole W, et al. Best practice for wound repair and regeneration use of cellular, acellular and matrix-like products (CAMPs). J Wound Care. 2023;32(Sup4b):S1-S31. https://doi.org/10.12968/jowc.2023.32.Sup4b.S1 DOI: https://doi.org/10.12968/jowc.2023.32.Sup4b.S1
American Medical Association. CPT 2024 Professional Edition. Chicago (IL): American Medical Association; 2023.
American Medical Association. CPT Assistant: guidance on skin substitute application codes 15271–15278. Chicago (IL): American Medical Association; 2020.
Food and Drug Administration. Summary of Safety and Effectiveness Data (SSED) for INTEGRA® Dermal Regeneration Template (PMA No. P900033/S008). Silver Spring (MD): FDA; 2002 Apr 19. https://www.accessdata.fda.gov/cdrh_docs/pdf/P900033S008b.pdf (accessed 13 May 2026)
Food and Drug Administration. Premarket Notification K021792 for Bilayer Matrix Wound Dressing (510(k)clearance). Silver Spring (MD): FDA; 2002 Aug 14. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K021792 (accessed 13 May 2026)
Kapp D, Carpenter S, Ferguson A, et al. Efficacy of a dehydrated porcine placental extracellular matrix for the treatment of multiple chronic wound types in a private practice model: a retrospective feasibility study. International Journal of Tissue Repair. 2026; 2(1). https://doi.org/10.63676/1p43y632 DOI: https://doi.org/10.63676/1p43y632
Carpenter S, Ferguson A, Bahadur D, Estapa A, Bahm J, Burst S. Efficacy of cellular and/or tissue-based product applications on all non-pressure injury chronic wound types in a Medicare private practice model. Wounds. 2025;37(8):292-304. https://doi.org/10.25270/wnds/25005 DOI: https://doi.org/10.25270/wnds/25005
Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453(7193):314-321. https://doi.org/10.1038/nature07039 DOI: https://doi.org/10.1038/nature07039
Schreml S, Szeimies RM, Prantl L, Landthaler M, Babilas P. Wound healing in the 21st century. J Am Acad Dermatol. 2010;63(5):866-881. https://doi.org/10.1016/j.jaad.2009.10.048 DOI: https://doi.org/10.1016/j.jaad.2009.10.048
Howaldt MN. Arterial and mixed leg ulcer. In: Téot L, Meaume S, Akita S, Del Marmol V, Probst S (eds). Diseases of the Veins and Arteries: Leg Ulcers. Springer; 2024:61–67. https://doi.org/10.1007/978-3-031-60954-1_7 DOI: https://doi.org/10.1007/978-3-031-60954-1_7
Alagha M, Alfatih A, Westby D, Walsh SR. Review of Mixed Arterial Venous Leg Ulcers (MAVLU) Disease in Contemporary Practice. Vasc Endovascular Surg. 2024;58(7):747-751. https://doi.org/10.1177/15385744241264336 DOI: https://doi.org/10.1177/15385744241264336
Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care. 2003;26(6):1879-1882. https://doi.org/10.2337/diacare.26.6.1879 DOI: https://doi.org/10.2337/diacare.26.6.1879
Snyder RJ, Cardinal M, Dauphinée DM, Stavosky J. A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks. Ostomy Wound Manage. 2010;56(3):44-50.
Noridian Healthcare Solutions. Local Coverage Determination (LCD): Wound and Ulcer Care (L38902). Fargo (ND): Noridian Healthcare Solutions; 2021. https://med.noridianmedicare.com/web/jfb/policies/lcds-and-articles/lcds/wound-and-ulcer-care (accessed 13 May 2026)
Social Security Act §1862(a)(1)(A), 42 U.S.C. §1395y(a)(1)(A). Centers for Medicare & Medicaid Services.
Medicare Program Integrity Manual. Pub. 100‑08, Ch. 13, §13.5.4. Baltimore (MD): CMS; current version [cited 2026 Apr 27]. https://www.cms.gov/regulations-and-guidance/guidance/manuals/internet-only-manuals-ioms (accessed 13 May 2026)
Centers for Medicare & Medicaid Services. Medicare Benefit Policy Manual. Pub. 100‑02, Ch. 15. Baltimore (MD): CMS; current version [cited 2026 Apr 27]. https://www.cms.gov/regulations-and-guidance/guidance/manuals/internet-only-manuals-ioms (accessed 13 May 2026)
Carpenter S, Cole W. Defining appropriate CAMPs administration: a response to the Medicare wastage guidance. J Wound Care. 2026;35(5):353–354. https://doi.org/10.12968/jowc.2026.0111 DOI: https://doi.org/10.12968/jowc.2026.0111
Venes D, editor. Taber’s Cyclopedic Medical Dictionary. 24th ed. Philadelphia (PA): F.A. Davis Company; 2021
Published
Data Availability Statement
Not applicable
Issue
Section
License
Copyright (c) 2026 International Journal of Tissue Repair
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
